Evidence map›Paper›PMID 33104876›Full record

ArticleSurgery today2021

The role of heparin bridging in lung cancer surgery: a nationwide database analysis.

Masataka Mori, Koki Ibayashi, Masatoshi Kanayama, Masaru Takenaka, Koji Kuroda, Keiji Muramatsu, Yoshihisa Fujino, Shinya Matsuda, Fumihiro Tanaka

Abstract read
PubMed Publisher
In one paragraph

Article in Surgery today, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 78% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Masataka MoriSecond Department of Surgery, School of Medicine, University of Occupational and Environmental Health, Yahatanishi, Kitakyushu, 807, Japan. masataka-m@med.uoeh-u.ac.jp.
Koki IbayashiDepartment of Environmental Epidemiology, University of Occupational and Environmental Health, Kitakyushu, Japan.
Masatoshi KanayamaSecond Department of Surgery, School of Medicine, University of Occupational and Environmental Health, Yahatanishi, Kitakyushu, 807, Japan.
Masaru TakenakaSecond Department of Surgery, School of Medicine, University of Occupational and Environmental Health, Yahatanishi, Kitakyushu, 807, Japan.
Koji KurodaSecond Department of Surgery, School of Medicine, University of Occupational and Environmental Health, Yahatanishi, Kitakyushu, 807, Japan.
Keiji MuramatsuDepartment of Preventive Medicine and Community Health, University of Occupational and Environmental Health, Kitakyushu, Japan.
Yoshihisa FujinoDepartment of Environmental Epidemiology, University of Occupational and Environmental Health, Kitakyushu, Japan.
Shinya MatsudaDepartment of Preventive Medicine and Community Health, University of Occupational and Environmental Health, Kitakyushu, Japan.
Fumihiro TanakaSecond Department of Surgery, School of Medicine, University of Occupational and Environmental Health, Yahatanishi, Kitakyushu, 807, Japan.
University of Occupational and Environmental Health Japan · JP

Funding

Ministry of Health, Labour, and Welfare, Japan H30-Policy-Designated-004
6 · The paper itself

Abstract

purposeThere is little evidence to demonstrate the impact of heparin bridging (HB) in major surgery. This study aimed to evaluate the benefits and risks of HB in lung cancer surgery by comparing HB and non-HB (NHB) groups.

methodsWe extracted patients who were taking an anticoagulant, were diagnosed with lung cancer, and underwent lung resection between April 2014 and March 2018 from a nationwide database in Japan. We compared the HB and NHB groups to determine the benefits and risks of HB. The proportion of postoperative thromboembolism and bleeding events between the HB and NHB groups was the primary outcome. We performed propensity score matching to remove any HB assignment bias.

resultsWe selected 2416 patients, and among these, 1068 patients had HB and 1348 did not. Propensity score matching extracted 1500 patients: 750 with HB and 750 without HB. After matching, a Chi-square test showed no significant difference in the incidence of postoperative thromboembolism (1.5% vs 0.9%, p value = 0.343) and bleeding events (5.9% vs 4.0%, p value = 0.124) between the two groups.

conclusionsThere was no significant difference in the incidence of postoperative thromboembolism and bleeding in the patients with and those without HB.

Indexed as

AgedAged, 80 and overAnticoagulantsChi-Square DistributionData AnalysisFemaleHemorrhageHeparinHumansIncidenceJapanLung NeoplasmsMalePostoperative ComplicationsPropensity ScoreThromboembolismAnticoagulantsHeparinAnti-clotting drugBleedingHeparin bridgingLung cancerThromboembolism

Identifiers

PMID33104876
OpenAlexW3093821762

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.